EUVIMEDEUVIMED entdecken
Crossref

Nicotinamide Riboside Improves Enteric Neuropathy in Streptozocin-Induced Diabetic Rats Through Myenteric Plexus Neuroprotection

Christopher J Costa iD, Melanie W Cohen, David C Goldberg, Wilfredo Mellado, Dianna E Willis

Digestive Diseases and Sciences · 2023

DOI: 10.1007/s10620-023-07913-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2023. Verfasst von Christopher J Costa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Quinnipiac University Frank H Netter MD School of Medicine, North Haven, CT, USA. chrcosta@uchc.edu. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Diabetic Neuropathies, Intestinal Pseudo-Obstruction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Institute of Nursing Research, American Diabetes Association Research Foundation, Burke Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Diabetes Mellitus causes a systemic oxidative stress due in part to the hyperglycemia and the reactive oxygen species generated. Up to 75% of diabetic patients present with an autonomic neuropathy affecting the Enteric Nervous System. Deficits in the human population are chronic dysmotilities with either increased (i.e., constipation) or decreased (i.e., diarrhea) total gastrointestinal transit times. These are recapitulated in the streptozocin-induced diabetic rat, which is a model of Type I Diabetes Mellitus. AIMS: Examine the effects that a precursor of nicotinamide adenosine dinucleotide (NAD), nicotinamide riboside (NR), had on the development of dysmotility in induced diabetic rats and if fecal microbiota transplant (FMT) could produce the same results. MATERIALS AND METHODS: Utilizing a 6-week treatment paradigm, NR was administered intraperitoneally every 48 h. Total gastrointestinal transit time was assessed weekly utilizing the carmine red method. Three weeks following hyperglycemic induction, FMT was performed between NR-treated animals and untreated animals. SIGNIFICANT RESULTS: There is improvement in overall gastrointestinal transit time with the use of NR. 16S microbiome sequencing demonstrated decreased alpha and beta diversity in induced diabetic rats without change in animals receiving FMT. Improvements in myenteric plexus ganglia density in small and large intestines in diabetic animals treated with NR were seen. CONCLUSIONS: NR treatment led to functional improvement in total gastrointestinal transit time in induced diabetic animals. This was associated with neuroprotection in the myenteric plexuses of both small and large intestines of induced diabetic rats. This represents an important first step in showing NR's benefit as a treatment for diabetic enteric neuropathy. Streptozocin-induced diabetic rats have improved transit times and increased myenteric plexus ganglia density when treated with intraperitoneal nicotinamide riboside.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalDiabetic NeuropathiesIntestinal Pseudo-ObstructionHumansRatsAnimalsMyenteric PlexusStreptozocinNeuroprotectionNiacinamidePyridinium Compounds

Stichwörter der Autor:innen

Diabetes complications (T578794)Diabetic neuropathies/drug therapy (D003929/Q000188)Intestinal Pseudo-obstruction/drug therapy (D007418/Q000188)Nicotinamide mononucleotide (M0014835)Rats, Sprague–Dawley (T051304)Streptozocin Diabetes Streptozotocin Diabetes (M0006151)

Substanzen

StreptozocinNiacinamidenicotinamide-beta-ribosidePyridinium Compounds

Autor:innen und Institutionen

  • Quinnipiac University Frank H Netter MD School of Medicine, North Haven, CT, USA. chrcosta@uchc.edu.
  • Burke Neurological Institute, 785 Mamaroneck Ave, White Plains, NY, 10605, USA. chrcosta@uchc.edu.
  • Graduate Medical Education, Internal Medicine Residency, UConn Health, 263 Farmington Ave, Farmington, CT, 06030-1235, USA. chrcosta@uchc.edu.
  • Burke Neurological Institute, 785 Mamaroneck Ave, White Plains, NY, 10605, USA.
  • Children's Hospital of Philadelphia, 3501 Civic Center Blvd, Philadelphia, PA, 19104, USA.
  • Weill Cornell Medicine Feil Family Brain and Mind Research Institute, New York, NY, USA.

ORCID-Profile: Christopher J Costa

Förderung

  • National Institute of Nursing Research
  • American Diabetes Association Research Foundation
  • Burke Foundation

Zitieren

APA

Costa, C. J., Cohen, M. W., Goldberg, D. C., Mellado, W., & Willis, D. E. (2023). Nicotinamide Riboside Improves Enteric Neuropathy in Streptozocin-Induced Diabetic Rats Through Myenteric Plexus Neuroprotection. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-023-07913-5

Vancouver

Costa CJ, Cohen MW, Goldberg DC, Mellado W, Willis DE. Nicotinamide Riboside Improves Enteric Neuropathy in Streptozocin-Induced Diabetic Rats Through Myenteric Plexus Neuroprotection. Digestive Diseases and Sciences. 2023. doi:10.1007/s10620-023-07913-5

BibTeX
@article{Costa2023,
  author = {Costa, Christopher J and Cohen, Melanie W and Goldberg, David C and Mellado, Wilfredo and Willis, Dianna E},
  title = {Nicotinamide Riboside Improves Enteric Neuropathy in Streptozocin-Induced Diabetic Rats Through Myenteric Plexus Neuroprotection},
  journal = {Digestive Diseases and Sciences},
  year = {2023},
  doi = {10.1007/s10620-023-07913-5}
}
Kostenlos starten →